BioSyent Schedules Q1 2020 Earnings Release For May 28, 2020
May 21, 2020 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 21, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2020 on...
FeraMAX® Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Fifth Consecutive Year
May 01, 2020 09:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 01, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that for the fifth consecutive year, FeraMAX® has been named the #1...
BIOSYENT ANNOUNCES GRANT OF RESTRICTED SHARE UNITS
March 31, 2020 19:41 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 31, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved today a grant of 129,125...
BioSyent Releases Results for Fourth Quarter and Full Year 2019
March 18, 2020 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 18, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December...
BIOSYENT SCHEDULES Q4 AND FULL YEAR 2019 EARNINGS RELEASE FOR MARCH 18, 2020
March 11, 2020 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 11, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and twelve months ended...
BioSyent Announces Adoption of Restricted Share Unit Plan
March 06, 2020 17:30 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 06, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a Restricted Share Unit Plan...
BioSyent Announces Renewal of Normal Course Issuer Bid
December 11, 2019 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...
BioSyent Signs Exclusive Agreement for Pain Management Products
November 25, 2019 17:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 25, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive License...
BioSyent Releases Results for Third Quarter and First Nine Months of 2019
November 20, 2019 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and nine months ended September...
BioSyent Schedules Q3 and YTD 2019 Earnings Release for November 20, 2019
November 12, 2019 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...